Table 2.
Analysis | Value |
---|---|
OCT analysis | |
Qualitative analysis | |
Lipid‐rich plaque, n (%) | 51 (92.7) |
TCFA, n (%) | 17 (30.9) |
Macrophage, n (%) | 47 (85.5) |
Microvessels, n (%) | 27 (49.1) |
Cholesterol crystal, n (%) | 17 (30.9) |
Calcification, n (%) | 40 (72.7) |
Layered plaque, n (%) | 38 (69.1) |
Culprit cause in ACS cases, n=9 | |
Plaque rupture, n (%) | 7 (77.8) |
Plaque erosion, n (%) | 2 (22.2) |
Quantitative analysis | |
Minimal flow area, mm2 | 1.19 (0.88–1.90) |
Reference lumen area, mm2 | 7.31±2.93 |
Area stenosis, % | 78.1±11.2 |
Lipid analysis | |
Thinnest FCT, μm | 87 (60–130) |
Max lipid arc, degree | 246 (148–360) |
Mean lipid arc, degree | 154±59 |
Lipid length, mm | 10.3 (6.4–13.3) |
Lipid index | 1407.6 (878.8–2419.2) |
Calcium analysis | |
No. of calcium in the culprit plaque, n | 1.0 (0.0–2.0) |
Total calcium index in the culprit plaque | 265.5 (0.0–1074.4) |
IVUS analysis | |
Normalized total atheroma volume, mm3 | 172.9±78.7 |
Percent atheroma volume, % | 62.1 (53.1–65.2) |
Plaque burden, % | 79.5±10.1 |
Values are n (%), median (interquartile range), or mean±SD. ACS indicates acute coronary syndrome; FCT, fibrous cap thickness; IVUS, intravascular ultrasound; OCT, optical coherence tomography; and TCFA, thin‐cap fibroatheroma.